CB Scientific, Inc. (CBSC)
USD 0.04
(12.39%)
USD 0.04
(12.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.63 Million USD | 22.61% |
| 2022 | -2.1 Million USD | 66.79% |
| 2021 | -6.34 Million USD | -46.55% |
| 2020 | -4.32 Million USD | -333.01% |
| 2019 | -999.45 Thousand USD | -1497.36% |
| 2018 | -62.56 Thousand USD | 94.47% |
| 2017 | -1.13 Million USD | -193.09% |
| 2016 | -386.01 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -264.41 Thousand USD | 20.33% |
| 2023 Q4 | -331.88 Thousand USD | 31.86% |
| 2023 Q3 | -487.02 Thousand USD | 0.85% |
| 2023 Q1 | -320.13 Thousand USD | 58.06% |
| 2023 Q2 | -491.2 Thousand USD | -53.44% |
| 2023 FY | -1.63 Million USD | 22.61% |
| 2022 Q2 | -448.57 Thousand USD | 3.64% |
| 2022 FY | -2.1 Million USD | 66.79% |
| 2022 Q4 | -763.28 Thousand USD | -77.83% |
| 2022 Q3 | -429.21 Thousand USD | 4.32% |
| 2022 Q1 | -465.5 Thousand USD | 68.42% |
| 2021 Q3 | -4 Million USD | -918.95% |
| 2021 Q1 | -471.89 Thousand USD | 89.31% |
| 2021 Q2 | -392.87 Thousand USD | 16.75% |
| 2021 Q4 | -1.47 Million USD | 63.17% |
| 2021 FY | -6.34 Million USD | -46.55% |
| 2020 FY | -4.32 Million USD | -333.01% |
| 2020 Q4 | -4.41 Million USD | 0.0% |
| 2019 FY | -999.45 Thousand USD | -1497.36% |
| 2018 FY | -62.56 Thousand USD | 94.47% |
| 2017 Q4 | -397.89 USD | 0.0% |
| 2017 FY | -1.13 Million USD | -193.09% |
| 2016 FY | -386.01 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -75.883% |
| Ansell Limited | 76.5 Million USD | 102.131% |
| Ansell Limited | 76.5 Million USD | 102.131% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 106.714% |
| BioLife Sciences Inc. | - USD | Infinity% |
| Psykey, Inc. | -1.32 Million USD | -23.135% |
| ConvaTec Group Plc | 130.3 Million USD | 101.251% |
| ConvaTec Group Plc | 130.3 Million USD | 101.251% |
| Encision Inc. | -691.78 Thousand USD | -135.658% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1049.589% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -595.597% |
| Innovative MedTech Inc. | -7.93 Million USD | 79.465% |
| LifePoint, Inc. | -15.23 Million USD | 89.297% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 76.065% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -243.933% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -494.012% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -255.151% |
| SmileDirectClub, Inc. | -86.4 Million USD | 98.113% |
| Sector 10, Inc. | 7036.00 USD | 23270.026% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.081% |
| SheerVision, Inc. | -71.37 Thousand USD | -2184.021% |
| United Health Products, Inc. | -2.62 Million USD | 37.854% |
| Vasamed, Inc. | -4.88 Million USD | 66.649% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 31.745% |
| Yubo International Biotech Limited | -1.2 Million USD | -35.316% |